MDMA Drug Urine Test Cassette yields a positive result when the Methylenedioxymethamphetamine in urine exceeds 500ng/mL.
MDMA Drug Urine Test Cassette
1. Product Details
Product Name: The MDMA Drug Urine Test Cassette
Materials Provided: Test devices, Droppers, Package insert
Methylenedioxymethamphetamine (ecstasy) is a designer drug first synthesized in 1914 by a German drug company for the treatment of obesity.Those who take the drug frequently report adverse effects, such as increased muscle tension and sweating. MDMA is not clearly a stimulant, although it has, in common with amphetamine drugs, a capacity to increase blood pressure and heart rate. MDMA does produce some perceptual changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision in some users.The mechanism of action of ecstasy is thought to be via release of the neurotransmitter serotonin. MDMA may also release dopamine, although the general opinion is that this is a secondary effect of the drug (Nichols and Oberlender, 1990). The most pervasive effect of MDMA, occurring in virtually all people who took a reasonable dose of the drug, was to produce a clenching of the jaws.
The MDMA Drug Urine Test Cassette is an immunoassay based on the principle of competitive binding. Drugs which may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody. During testing, a urine specimen migrates upward by capillary action
Methylenedioxymethamphetamine, if present in the urine specimen below 500ng/mL, will not saturate the binding sites of antibody-coated particles in the test strip. The antibody-coated particles will then be captured by immobilized Methylenedioxymethamphetamine conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the Methylenedioxy methamphetamine level exceeds 500ng/mL because it will saturate all the binding sites of anti-Methylenedioxy methamphetamine antibodies.A drug-positive urine specimen will not generate a colored line in the test line region because of drug competition, while a drug-negative urine specimen or a specimen containing a drug concentration less than the cut-off will generate a line in the test line region. To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.
4. Directions for Use
Allow the test device, urine specimen, and/or controls to reach room temperature(15-30ºC) priortotesting.
(1)Bring the pouch to room temperature before opening it. Remove the test device from the sealed pouch and use it as soon as possible.
(2)Place the test device on a clean and level surface. Hold the dropper vertically and transfer 3 full drops of urine (approx. 100μL) to the specimen well (S) of the test device, and then start the timer. Avoid trapping air bubbles in the specimen well (S). See the illustration below.
(3)Wait for the colored line(s) to appear. The result should be read at 5 minutes. Do not interpret the result after 10 minutes.
5. Quality Control
A procedural control is included in the test. A colored line appearing in the control region (C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique. Control standards are not supplied with this kit; however it is recommended that positive and negative controls be tested as good laboratory practice to confirm the test procedure and to verify proper
test performance. Users should follow national and local guidelines for testing QC materials.
Hangzhou Laihe Biotech Co., Ltd
Founded by Dr returned from United States in February 2012, today Laihe Biotech have a team of experienced scientists researching and developing diagnostic products, and have already built an independent POCT platform which including various rapid test products like Cardiac Marker Series (cTnI, NT-proBNP, H-FABP, etc.), Inflammation Series (ds-CRP, PCT, etc.), Tumor Marker Series (AFP, CEA, etc.), Diabetes Monitoring Series (HbA1c), Fertility Series (TORCH) and Infectious Diseases Series. We continue to be innovative, and promote in-vitro diagnostic products in a miniaturized, individualized, family-oriented and low-cost way.
Address: Room 521 Floor 5 & Floor 1,Building No. 2B,Tianhe High-Tech Park,No. 688,Bin'an Road,Changhe Sub-district,Binjiang District,Hangzhou City,Zhejiang Province,China